Related Experiment Video
Updated: Sep 16, 2025

08:35
In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
10.3K
The Fragile Balance: Autophagy's Role in Neurodegenerative Disease Progression
Bharat Bhushan1, Meenakshi Dhanawat2, Garima3
1Institute of Pharmaceutical Research GLA University, Mathura, 281406, India.
Current Neuropharmacology
|July 7, 2025
Summary
Autophagy, a cellular process, is crucial for maintaining homeostasis and preventing neurodegenerative diseases. Activating autophagy shows potential as a therapeutic strategy for neurological conditions.
Area of Science:
- Cell Biology
- Molecular Biology
- Neuroscience
Background:
- Autophagy is a fundamental cellular process for degrading and recycling intracellular components, essential for maintaining cellular homeostasis.
- Dysfunctional autophagy is implicated in various diseases, including cancer and neurological disorders.
- Cellular quality control mechanisms, including autophagy and the ubiquitin-proteasome system, are vital for protein and organelle integrity.
Purpose of the Study:
- To review recent advancements in understanding the link between autophagic abnormalities and neurological disorders.
- To explore the role of autophagy in the pathophysiology of neurodegenerative diseases.
- To propose autophagy activation as a potential therapeutic strategy for neurological conditions.
Main Methods:
- Literature review of recent research on autophagy and neurological disorders.
- Analysis of the role of autophagy-related genes and proteins in neurodegeneration.
- Examination of pathogenic mechanisms involving proteins like alpha-synuclein and amyloid beta.
Main Results:
- Autophagy malfunction is associated with the accumulation of misfolded proteins, a hallmark of many neurodegenerative diseases.
- Mutations in autophagy-related genes are linked to neurodegenerative conditions.
- Pathogenic proteins can directly impair the autophagic system, contributing to disease progression.
Conclusions:
- Aberrant autophagy plays a significant role in the development and progression of neurological disorders.
- Targeting and activating autophagy presents a promising therapeutic avenue for treating neurodegenerative diseases.
- Further research into the intricate relationship between autophagy and neurological health is warranted.
Related Concept Videos
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Delivery Pathways to the Lysosome
7.3K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.3K
Autophagic Cell Death
3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Parkinson's Disease: Overview
716
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
716
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
The Proteasome
1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K

